http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_37ec2e2e2e84088e05afe5a645d3616f
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Keun |
| name | Hector C Keun Hector C. Keun |
| given-name | Hector C Hector C. |
| organization-name | Department of Surgery and Cancer, Imperial College London, SW7 2AZ London, United Kingdom Biomolecular Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Sir Alexander Fleming Building, South Kensington, London, SW7 2AZ, U.K.; MRC-HPA Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, Norfolk Place, London, W2 1PG, U.K. Division of Cancer, Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, U.K. Department of Surgery & Cancer and Department of Metabolism,Digestion & Reproduction,Imperial College London,London,United Kingdom Department of Biomolecular Medicine, Division of Surgery, Oncology, Reproductive Biology and Anaesthetics (SORA), Faculty of Medicine, Sir Alexander Fleming Building, Imperial College London, London SW7 2AZ, Centre for Ecology and Hydrology, Monks Wood, Abbots Ripton, Huntingdon PE28 2LS, and Cardiff School of Biosciences, Main Building, Cardiff University, Park Place, Cardiff CF10 3TL, Wales, United Kingdom Department of Biomolecular Medicine, Division of Surgery, Oncology, Reproductive Biology and Anaesthetics, Faculty of Medicine, Imperial College, London, SW7 2AZ, UK Department of Surgery and Cancer, Imperial College London, London, W12 0NN, U.K. Biomolecular Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, United Kingdom Department of Surgery and Cancer, Imperial College London, London, United Kingdom Medical Research Council Toxicology Unit, University of Leicester, Lancaster Road, Leicester LE1 9HN, U.K., Department of Investigative Preclinical Toxicology, Safety Assessment, GSK R&D Ltd., Ware, U.K., University of Würzburg, Department of Toxicology, DE-97078 Würzburg, Germany, Cancer Biomarkers and Prevention Group, Biocentre, University of Leicester, University Road, Leicester LE1 7RH, U.K., and Department of Biomolecular Medicine, Division of Surgery, Oncology, Reproductive Biology and... Department of Surgery & Cancer and Department of Metabolism, Digestion & Reproduction, Imperial College London, London, United Kingdom Imperial College London, Biological Chemistry, Biomedical Sciences Division, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, UK. Biomolecular Medicine, Department of Surgery and Cancer, Faculty of Medicine, Sir Alexander Fleming Building, Imperial College London, London, SW7 2AZ; INSERM, U920, 33405 Talence, France; and Université Bordeaux I, 33405 Talence, France Department of Biomolecular Medicine, Division of Surgery, Oncology, Reproductive Biology and Anaesthetics, Faculty of Medicine, Imperial College London, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, United Kingdom Authors' Affiliations: 1Biomolecular Medicine, Department of Surgery & Cancer, Faculty of Medicine, Imperial College London South Kensington Campus; 2Division of Investigative Sciences, Imperial College London Hammersmith Campus, London, United Kingdom; and 3Department of Medical Oncology, University of Sydney Concord Hospital, Concord, Sydney, Australia The Harris Laboratory for Prostate Cancer Research, Division of Surgery, Oncology, Reproductive Biology & Anesthetics, Medical Oncology, Imperial College, London W12 0NN, and Biological Chemistry, Division of Biomedical Sciences, Imperial College, South Kensington, London SW7 2AZ Section of Biomolecular Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, SW7 2AZ London, United Kingdom Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Exhibition Road, South Kensington, London SW7 2AZ, London, UK Biomolecular Medicine, Department of Surgery and Cancer, Faculty of Medicine, Sir Alexander Fleming Building, Imperial College London, London, SW7 2AZ, U.K. Imperial College London, Department of Biomolecular Medicine, Division of Surgery, Oncology, Reproductive Biology and Anaesthetics (SORA), Faculty of Medicine, South Kensington, London, SW7 2AZ, UK. Biomolecular Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, South Kensington, London, UK. h.keun@imperial.ac.uk Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, Singapore 117543, Singapore, Colorectal Cancer Research Laboratory, Department of Colorectal Surgery, Singapore General Hospital, Outram Road, Block 6 Level 7, Singapore 169608, Singapore, and Department of Biomolecular Medicine, Division of Surgery, Oncology, Reproductive Biology and Anaesthetics, Faculty of Medicine, Imperial College London, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ,... 1 Department of Toxicogenomics, School of Oncology and Developmental Biology (GROW), Maastricht University, 6200 MD Maastricht, The Netherlands, 2Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, 02215, MA, USA, 3European Molecular Biology Laboratory – European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambs CB10 1SD, UK, 4Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London, South Kensington, London SW7 2AZ, UK, 5Department of Bioinformatics – BiGCaT, Maastricht University, 6200 MD Maastricht, The Netherlands, 6Genedata AG, CH-4053 Basel, Switzerland, 7Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany, 8Center of Physiology and Pathophysiology, Institute of Neurophysiology, University of Cologne, Cologne 50931, Germany and 9European Commission, Joint Research Centre, 21027 Ispra VA, Italy Biomolecular Medicine, Department of Surgery and Cancer, Faculty of Medicine Imperial College London Sir Alexander Fleming Building, South Kensington London SW7 2AZ UK Authors' Affiliations: Departments of 1Surgery and Cancer and 2Histopathology, Imperial College London, London, United Kingdom 1 Department of Surgery and Cancer, Section of Computational and Systems Medicine, Imperial College London, Exhibition Road, London SW7 2AZ, UK and 2 Translational Research Unit, Chulabhorn Research Institute, Bangkok 10210, Thailand 2Department of Surgery and Cancer, Imperial College London, London, United Kingdom. Biological Chemistry, Biomedical Sciences, Faculty of Medicine, Imperial College of Science, Technology and Medicine, London, SW7 2AZ, United Kingdom Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK Division of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London SW7 2AZ, UK; Cancer Metabolism and Systems Toxicology Group, Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London W12 0NN, UK Biomolecular Medicine, Sir Alexander Fleming Building, Division of Surgery, Oncology, Reproductive Biology, and Anesthetics, Faculty of Medicine, Imperial College London, SW7 2AZ, United Kingdom Cancer Metabolism & Systems Toxicology Group, Division of Cancer, Department of Surgery and Cancer Imperial College London London UK Biomolecular Medicine, Department of Surgery and Cancer, Imperial College London, London, United Kingdom; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London W12 0NN, United Kingdom Biomolecular Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, United Kingdom, Metabonomics Evaluation Group, Pfizer Global R&D, Ann Arbor, Michigan 48105, School of Life Science and Biotechnology, Korea University, 5-1, Anam-dong, Sungbuk-gu, Seoul 136-701, Republic of Korea, and Bristol-Myers Squibb, Route 206 & Province Line Road, Princeton, New Jersey 08543-4000 Department of Surgery and Cancer Imperial College London London United Kingdom 5Department of Surgery and Cancer, Imperial College, London. Biological Chemistry, Biomedical Sciences, Faculty of Medicine, Imperial College of Science, Technology and Medicine, London, SW7 2AZ, U.K., and Pharma Preclinical Research Basel, F. Hoffmann−La Roche AG, CH-4070-Basel, Switzerland Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, U.K. 2Department of Surgery and Cancer, Imperial College, London, United Kingdom. Department of Surgery and Cancer, Imperial College London, London W12 0NN, United Kingdom; Authors' Affiliations: 1Biomolecular Medicine and 2Medicine and Endocrinology, Imperial College, 3Department of Oncology, Imperial College and Imperial College Healthcare NHS Trust, and 4Department of Surgery, Imperial College Healthcare NHS Trust, London, United Kingdom Biomolecular Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, United Kingdom; Biological Chemistry, Biomedical Sciences, Faculty of Medicine, Imperial College of Science, Technology and Medicine, London, SW7 2AZ, U.K., and Bruker Biospin AG, Industriestrasse 26, CH-8117, Faellanden, Switzerland Department of Biomolecular Medicine, Division of Surgery, Oncology, Reproductive Biology and Anaesthetics, Faculty of Medicine, Imperial College London, Sir Alexander Fleming Building, South Kensington, London, SW7 2AZ, UK Department of Biomolecular Medicine, Imperial College London, Division of Surgery, Oncology, Reproductive Biology & Anaesthetics, Faculty of Medicine, Sir Alexander Fleming Building, South Kensington, London, SW7 2AZ, United Kingdom, Incyte Corporation, Wilmington, Delaware 19880-0400, and Discovery Toxicology, Bristol-Myers Squibb Company, Princeton, New Jersey 08543 Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, MRC-HPA Centre for Environment and Health, Imperial College London, London, United Kingdom; Department of Surgery and Cancer, Faculty of Medicine, Biomolecular Medicine, Imperial College London, London, United Kingdom Department of Biomolecular Medicine, Division of Surgery, Oncology, Reproductive Biology and Anaesthetics, Faculty of Medicine, Imperial College London, Sir Alexander Fleming Building, South Kensington Campus, London SW7 2AZ, U.K., Department of Public Health and Epidemiology, Swiss Tropical Institute, P.O. Box CH-4002, Basel, Switzerland, Waters Corporation, 34 Maple Street, Milford, Massachusetts 01757, and AstraZeneca, Department of Drug Metabolism and Pharmacokinetics, Mereside, Alderley Park,... Biomolecular Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, SW7 2AZ, U.K., Bristol Myers-Squibb, Route 206 and Province Line Road, Princeton, New Jersey 08543-4000, Drug Safety Research and Development, Pfizer Global Research and Development, Chazy, New York 12921, and Waters Corporation, 34 Maple Street, Milford, Massachusetts 01757 Computational and Systems Medicine, Department of Surgery and Cancer, Faculty of Medicine, Sir Alexander Fleming Building, Imperial College London, South Kensington, SW7 2AZ, U.K. Biomolecular Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Sir Alexander Fleming Building, South Kensington, London, United Kingdom, SW7 2AZ, and Department of Toxicology, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussels, Belgium 1 Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany, 2Department of Toxicogenomics, Maastricht University, Universiteitssingel 50, Maastricht, The Netherlands and 3Biomolecular Medicine, Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK Cancer Metabolism & Systems Toxicology Group, Division of Cancer, Department of Surgery & Cancer and Division of Systems Medicine, Department of Metabolism, Digestion & Reproduction, Imperial College London, Hammersmith Hospital Campus Department of Pharmaceutical Chemistry, Semmelweis University, Hõgyes Endre u. 9, Budapest 1092, Hungary, and Department of Biomolecular Medicine, Division of Surgery, Oncology, Reproductive Biology and Anesthetics, Faculty of Medicine, Imperial College London, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, U.K. Computational and Systems Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Sir Alexander Fleming Building, South Kensington, London, SW7 2AZ, U.K. Division of Cancer, Department of Surgery and Cancer Imperial College London, Institute of Reproductive and Developmental Biology (IRDB), Hammersmith Hospital London United Kingdom Department of Biomolecular Medicine, Division of Surgery, Oncology, Reproductive Biology and Anaesthetics, Faculty of Medicine, Imperial College London, Sir Alexander Fleming Building, South Kensington, London, United Kingdom, SW7 2AZ, Cancer Research U.K., Lincoln’s Inn Fields, London, United Kingdom, WC2A 3PX, Cancer Biomarkers and Prevention Group, Dept of Cancer Studies and Molecular Medicine, University of Leicester, United Kingdom, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire,... Imperial College London (ICL), London, United Kingdom |
Incoming Links
Total number of triples: 186.